Cannabis Solidifies its Global Stature as Key Nations Adopt More Lenient Regulations

Cannabis Solidifies its Global Stature as Key Nations Adopt More Lenient Regulations

FinancialBuzz.com News Commentary

PR Newswire

NEW YORK, April 10, 2019

NEW YORK, April 10, 2019 /PRNewswire/ -- Cannabis has grown into a global force recently, driven specifically by the spur of ongoing legalization efforts. Despite cannabis still being illegal in most countries, the movement for legalization is stronger than it's ever been. In October 2018, Canada became the second country to ever legalize cannabis entirely, joining Uruguay on that short list. Shortly after, the U.S. held its mid-term elections in November where Missouri, Michigan, and Utah all legalized cannabis on a certain level. Meanwhile, globally, a string of countries such as Australia, Germany, and South Korea began accelerating their medical cannabis programs. Furthermore, Argentina, Columbia, the Netherlands, Spain, and many others have decriminalized cannabis, allowing for personal moderate consumption. Moreover, hemp-derived CBD products like tinctures, creams, and oils are seeing massive exposure because they are legal within the U.S. The proliferation of cannabis legalization is leading to an explosive emerging global marketplace, where many investors and entrepreneurs have noticed. Cannabis-based companies have expanded significantly over the past few years due to these political trends as well. And many of the top players within the industry have already implemented international operations, as the medical cannabis industry currently accounts for the majority of the market share globally. However, the North American region is expected to shift the market share from medical to recreational, primarily due to U.S. states like Colorado, California, Washington, and Nevada and the maturing Canadian recreational market. According to data compiled by Mordor Intelligence, the global cannabis market was valued at USD 7.7 Billion in 2016 and is expected to reach USD 65 Billion by 2023. Additionally, the market is expected to grow at a robust CAGR of 37% throughout the forecast period from 2019 to 2024. WeedMD Inc. (OTC: WDDMF) (TSX-V: WMD), Tilray, Inc. (NASDAQ: TLRY), Canopy Growth Corporation (NYSE: CGC) (TSX: WEED), New Age Beverages Corporation (NASDAQ: NBEV), Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON)

The cannabis industry still remains in its infancy stage, due to the enforced regulatory restrictions. Due to the Single Convention on Narcotic Drugs, cannabis remains a Schedule 1 drug internationally, which is the strictest regulation. However, the World Health Organization (WHO) proposed a recommendation to reschedule cannabis due to its medical benefits. Furthermore, the U.S. Drug Enforcement Agency took notice and delisted CBD as a Schedule 1 and reclassified it as a Schedule 5. The United Nations Commission met throughout March 2019 to discuss matters of cannabis legalization. The U.S. in particular was interested in discussing the legality matter revolving around cannabis. Additionally, the U.S. Food and Drug Administration is holding its first public hearing on CBD in May, as the agency looks to legalize cannabis in food and drinks. Outgoing FDA Commissioner Scott Gottlieb is collecting data to prove the credibility of cannabis and its therapeutic effects. Previously, cannabis was heavily restricted internationally and resulted in harsh consequences if users were caught. Now, the industry has transitioned after many countries began to explore opportunities within the market. "The industry is at about 5 percent of what it will be someday," concurs Tyler Stratford, Director of Client Operations for cannabis consulting firm Canna Advisors. "Even if the path forward isn't straight, we're certainly on a path forward. The tide has changed, and there's no turning it back now."

WeedMD Inc. (OTCQX: WDDMF) (TSX-V: WMD) is also listed on the TSX Venture Exchange under the ticker (TSX-V: WMD) and a federally-licensed producer and distributor of medical-grade cannabis, just announced breaking cannabis news this morning that, "it has closed on the purchase of an additional 60 acres of prime land located directly adjacent to its 98-acre Strathroy property. WeedMD's outdoor grow now has the potential to increase to more than 100 acres. As previously announced, the Company has applied to Health Canada for an amendment to its Strathroy licence to expand beyond its greenhouse cultivation with an initial 25-acre, low-cost, outdoor grow operation in 2019. Link to release here. An additional 25 acres had previously been planned to come online as Phase II in 2020. With today's announcement, Phase II will increase to 75 acres for an overall outdoor cultivation of 100 acres online by 2020. 

Pending Health Canada approval, WeedMD's outdoor grow is expected to increase its total yield to more than 100,000 kgs of cannabis in 2020 and more than 150,000 kgs when combined with its greenhouse cultivation. Outdoor grow video here: https://www.youtube.com/watch?v=QnApYAnXDtw 

"With the amalgamation of this property and our existing licensed footprint, we now own more than 160 acres of contiguous land in Strathroy – that's 100 adjoining acres of prime workable agricultural land for outdoor cultivation. WeedMD is well-positioned to be the industry leader setting the benchmark for low-cost, scalable, quality-driven outdoor production in Canada," said Keith Merker, CEO of WeedMD. "As one of the first out of the gate, our experienced cultivation team has started onsite preparedness with ready-tested genetics and clones being propagated at our state-of-the-art greenhouse. The ability to produce consistent strains for dried flower, extracts and concentrates at a fraction of the cost of other production platforms will give us a strategic edge as we expand our product lines and commercial reach with our first outdoor harvest expected in fall 2019." 

"Our Strathroy property was strategically selected in 2017 for its modern greenhouse and future growth potential. The vast outdoor property has full sunlight, an abundance of air flow, a protective buffer zone of trees and proximity to our infrastructure and propagation operations at the greenhouse. We have now capitalized on the opportunity to expand across perfectly-maintained adjacent lands already primed for outdoor cultivation - all of which can now be easily folded into our licensed property," said Derek Pedro, Chief Cannabis Officer of WeedMD. "With the purchase of the adjacent 60 acres of land for outdoor grow, we're well on our way to rapidly scaling production, with Phase II bringing us to full capacity in 2020."

About WeedMD Inc. - WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed producer and distributor of cannabis products for both the medical and adult-use markets. The Company owns and operates two facilities: a 26,000 sq. ft. indoor facility in Aylmer, Ontario and a state-of-the-art greenhouse and outdoor facility located in Strathroy, Ontario. The Company currently has 136,000 square feet of licensed production space and is expected to have a total footprint of more than 550,000 square feet of indoor and greenhouse production in addition to more than 25 acres of outdoor cultivation space online in the first half of 2019. WeedMD has a multi-channeled distribution strategy that includes selling directly to medical patients, strategic relationships across the seniors' market and supply agreements with Shoppers Drug Mart as well as six provincial distribution agencies"

For our latest "Buzz on the Street" Show featuring WeedMD Inc. recent corporate news, please head over to: https://www.youtube.com/watch?v=5Ye5zahoypA

Tilray, Inc. (NASDAQ: TLRY) is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in twelve countries spanning five continents. Recently, Natura Naturals Inc., a wholly-owned subsidiary of Tilray, Inc. and High Park Holdings Ltd., has received a standard processing license under the Cannabis Act. The Natura greenhouse facility, which previously held a standard cultivation license, will now be able to manufacture a wide range of cannabis form factors from cannabis starting material, including oil, pre-rolls, and novel formats such as topicals and edibles. Natura, which will operate under High Park Gardens Inc., was acquired by Tilray in February 2019 to serve the adult-use and medical cannabis market in Canada alongside Tilray's existing operations. The site is a 662,000 sq. ft. greenhouse facility with 155,000 sq. ft. licensed for cultivation. The addition of a standard processing license means that High Park Gardens will be able to process cannabis raw material cultivated on site – as well as raw material sourced from other cannabis licensees – into a variety of value-add product formats. This development provides Tilray's facilities additional flexibility in the manufacture of products for the Canadian cannabis market, and in the development of novel products in preparation for the legalization of additional cannabis products, including tinctures, concentrates and edibles, in Canada later this year. "The acquisition of High Park Gardens in February allowed us to significantly increase our production footprint," says Greg Christopher, EVP Operations, Tilray. "With this additional licensing, we're pleased to have expanded Tilray and High Park's capacity to develop and manufacture high-quality branded products for the Canadian market."

Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. Canopy Growth Corporation recently announced that it has received a cultivation license from Health Canada for its facility in Fredericton, New Brunswick. With this licensing, Canopy Growth predicts the facility will initially produce more than 5,000kg of cannabis annually, with first harvests expected to become available to the market within six months. Developed in collaboration with Canopy Rivers Inc. (TSXV: RIV) and operating under Canopy Growth's flagship Tweed brand, the facility will support the Company's global and local operations with high quality, large-scale cannabis production capabilities that will serve the needs of recreational and medical customers. To meet that demand, Canopy Growth expects to create more than 130 jobs at the Fredericton plant. "New Brunswick has emerged as a leader in the legal cannabis sector and the province is an excellent place to do business," said Bruce Linton, co-Chief Executive Officer and Chairman, Canopy Growth. "We will leverage our existing operational expertise to ensure we support the needs of our customers while making a meaningful contribution to the local economy primarily through new job creation."

New Age Beverages Corporation (NASDAQ: NBEV) is a Colorado and Utah-based healthy beverage company dedicated to inspiring and educating consumers to live healthy. New Age Beverages Corporation recently announced the distribution expansion of their Marley brand with Walmart, the world's largest retailer. Following a complete redevelopment of the Marley portfolio following the acquisition by New Age in mid-2017, which included the development and launch of Organic Marley Mate and Marley Cold Brew, the Marley brand was one of the New Age's leading brands in growth in 2018 with increased demand of more than 70%. Marley Mate led its segment and drove category growth, and the resurgence of the Marley Mellow Mood Relaxation Drinks following its remake has paved the way for the launch of Marley Mellow Mood + CBD, which is launching globally in 2019. Craig Thibodeau, Vice President of Key Accounts for New Age stated, "This is such a great accomplishment for New Age to gain its first national distribution, and to do so with the world's largest retailer in Walmart. This is just the first initiative that we expect to do with them on the Marley brand and other New Age products on which we are in active discussions. We know Walmart is equally as committed as New Age to providing healthier products for their customers, and we expect to make the full portfolio of New Age's better-for-you products available as we expand the relationship."

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) is a globally diversified and vertically integrated cannabis company with a presence across five continents. Cronos Group Inc. recently announced that the CAD 2.4 Billion equity investment in the Company by Altria Group, Inc. (NYSE: MO) has closed. As previously announced, Altria's investment represents an approximate 45% ownership interest in Cronos Group. Altria also has a warrant to acquire additional ownership in Cronos Group, which is exercisable over the next four years. If exercised in full   , the warrant would increase Altria's ownership in Cronos Group to approximately 55% and provide Cronos Group with additional proceeds of approximately CAD 1.4 Billion. "We are delighted to close this transaction and kick-off a relationship that we expect to lead to significant growth and value creation," said Mike Gorenstein, Cronos Group's Chairman, President and Chief Executive Officer. "Altria's investment and the services they will provide to Cronos Group will enhance our financial resources, and allow us to expand our product development and commercialization capabilities, and regulatory expertise to better position Cronos Group to compete, scale and lead the rapidly growing global cannabis industry. We look forward to the many opportunities we expect this relationship to create."

Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia

Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

About FinancialBuzz.com  

FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For WeedMD Inc. financial and corporate news dissemination, FinancialBuzz.com has been compensated five thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com.

Media Contact:
info@financialbuzz.com
+1-877-601-1879

Url: www.FinancialBuzz.com

Voltar noticias em Inglês